F. Michael Ball Named President of Allergan

Botox maker Allergan Inc. has appointed F. Michael Ball president, effective Feb. 1, succeeding David E.I. Pyott.

The company said Pyott would retain his positions as chairman and chief executive. Ball, 49, who joined the company in 1995, was named president of pharmaceuticals in 2003.

“In his new role, Mike will take on responsibility for the integration of Inamed as well as continuing to drive focus within our specialty franchises to further increase our overall growth and profitability,” the company said in a statement.

Ball earned $846,254 in salary and bonus in 2004, according to the company’s most recent proxy statement. The Irvine company announced Ball’s promotion Thursday.

Besides Botox, Allergan markets eye-care drugs. In 2005, the company had net income of $385.8 million on revenue of $2.3 billion.

Allergan agreed to acquire Inamed Corp. for $3.2 billion, topping a bid by Medicis Pharmaceutical Corp. Allergan expects the Federal Trade Commission to clear the purchase within a few weeks.

Allergan shares closed Friday at $112.98, down 11 cents. The stock has risen 4.6% this year.